Similia Vol 36 No 1 – June 2023
Author: Dr Isaac Golden PhD
Abstract
This paper reports on a prospective in-clinic survey of the homeopathic remedies 2022DOV (see Appendix 1), BUAU, PF, AZ, MD and NV purchased between 1/1/2022 and 5/9/2022, and used for a variety of purposes when dealing with SARS-CoV-2, shedding symptoms and ‘vaccine’ injury.
Method
The emails of individuals who purchased the targeted remedies for themselves and family and friends between 1 January 2022 to 5 September 2022 were collected, as well as the emails of practitioners who purchased the remedies to distribute to their patients during this period. Four email reminders were sent from 1 September to 27 September 2022 to purchasers requesting their participation in the Survey. Results were collected and tabulated.
Results
The results of the Survey are summarised in thirteen tables. They show a very low rate of reactions to 2022DOV, with around 70% effectiveness to protect recipients against the disease and somewhat less to protect against shedding. The use of BUAU to treat SARS-CoV-2 symptoms, to treat shedding symptoms and to treat post- ‘vaccination’ symptoms is high, as is the effectiveness of ‘vaccine’ potencies to treat ‘vaccine’ injury.
Discussion
The effectiveness of the preventative 2022DOV was difficult to determine, although an effectiveness of over 70% is likely. The ability of the remedy to protect against shedding is less certain. The effectiveness of the remedy BUAU to treat adverse effects of the spike protein from shedding, from being ‘vaccinated’ and from the disease was strong. The effectiveness of ‘vaccine’ potencies to treat ‘vaccine’ injuries was very strong.
Conclusion
Homeopathic options have much to offer in the prevention and treatment of SARS-CoV-2, the treatment of the effects of shedding from ‘vaccinated’ people on both ‘vaccinated’ and ‘unvaccinated’ people, and to treat injury caused by the various Covid-19 ‘vaccines’.
What is new?
The article provides new insights into the potential value of specific homeopathic remedies to prevent and treat the Omicron variant of SARS-CoV-2 and to treat shedding, and ‘vaccine’ injuries.